Medifast, Inc.
MED
$14.00
-$0.09-0.64%
| Weiss Ratings | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | C- | |||
| Rating Factors | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.38 | |||
| Price History | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.71% | |||
| 30-Day Total Return | -8.62% | |||
| 60-Day Total Return | -29.86% | |||
| 90-Day Total Return | -20.36% | |||
| Year to Date Total Return | -19.03% | |||
| 1-Year Total Return | -63.20% | |||
| 2-Year Total Return | -91.79% | |||
| 3-Year Total Return | -102.08% | |||
| 5-Year Total Return | -97.26% | |||
| 52-Week High % Change | -65.05% | |||
| 52-Week Low % Change | 3.83% | |||
| Price | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $40.32 | |||
| 52-Week Low Price | $13.57 | |||
| 52-Week Low Price (Date) | Feb 20, 2025 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 150.18M | |||
| Enterprise Value | 3.96M | |||
| Price/Earnings (TTM) | 78.32 | |||
| Earnings Per Share (TTM) | 0.18 | |||
| Earnings Per Share Growth | -98.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.26 | |||
| Price/Book (Q) | 0.71 | |||
| Enterprise Value/Revenue (TTM) | 0.01 | |||
| Price | $14.00 | |||
| Enterprise Value/EBITDA (TTM) | 0.29 | |||
| Enterprise Value/EBIT | 0.95 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 10.98M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $1.65 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 34.18% | |||
| Dividend Per Share (Most Recent) | $1.65 | |||
| Company Info | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 410 581 8042 | |||
| Address | 100 International Drive Baltimore, MD 21202 | |||
| Website | medifastinc.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.69% | |||
| Profit Margin | 0.34% | |||
| Management Effectiveness | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.88% | |||
| Return on Equity | 1.02% | |||
| Income Statement | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 602.46M | |||
| Total Revenue (TTM) | 602.46M | |||
| Revenue Per Share | $54.85 | |||
| Gross Profit (TTM) | 444.62M | |||
| EBITDA (TTM) | 13.80M | |||
| EBIT (TTM) | 4.18M | |||
| Net Income (TTM) | 2.09M | |||
| Net Income Avl. to Common (TTM) | 2.09M | |||
| Total Revenue Growth (Q YOY) | -37.70% | |||
| Earnings Growth (Q YOY) | -86.73% | |||
| EPS Diluted (TTM) | 0.18 | |||
| EPS Diluted Growth (Q YOY) | -87.20% | |||
| Balance Sheet | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 162.34M | |||
| Cash Per Share (Q) | $14.78 | |||
| Total Current Assets (Q) | 214.40M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 210.11M | |||
| Current Ratio (Q) | 3.342 | |||
| Book Value Per Share (Q) | $19.71 | |||
| Total Assets (Q) | 284.21M | |||
| Total Current Liabilities (Q) | 64.16M | |||
| Total Debt (Q) | 16.13M | |||
| Total Liabilities (Q) | 74.10M | |||
| Total Common Equity (Q) | 210.11M | |||
| Cash Flow | MED - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -26.52M | |||
| Cash from Financing (TTM) | -1.52M | |||
| Net Change in Cash (TTM) | -3.51M | |||
| Levered Free Cash Flow (TTM) | -699.20K | |||
| Cash from Operations (TTM) | 24.48M | |||
